EUVIMEDEUVIMED entdecken
Crossref

DIA proteomic and PRM validation through human granulose cells profiles screen suitable biomarkers for polycystic ovary syndrome patients

Faying Liu, Lifeng Tian, Ying Zhang, Wei Deng, Xiaoyun Xu, Yang Zou, Ruifang An

Journal of Proteomics · 2024-10 · 309 · 105332

DOI: 10.1016/j.jprot.2024.105332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2024-10. Verfasst von Faying Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China; Central Laboratory, Jian…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Biomarkers, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Jiangxi Provincial Department of Science and Technology, Jiangxi Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study is to identify differentially expressed proteins (DEPs) in granulose cells (GCs) from women with or withoutpolycystic ovary syndrome (PCOS) via data independent acquisition (DIA) proteomic analysis.A total of 63 women were recruited for this study, 34 PCOS patients as experimental group (P), and 29 women without PCOS as Normal group (NP). DIA-based proteomic analysis was performed to identify DEPs in GCs between the P and NP samples. Certain typical DEPs were further validated by Parallel reaction monitoring (PRM), and correlation analysis was performed between these DEPs and the clinical characteristics.Cell vitality was measured by CCK-8 assay. DIA analysis revealed 174 significantly DEPs, of which 7 were upregulated and 167 downregulated. Bioinformatics analysis was performed to analysis the significantly DEPs. The PRM experiment confirmed TOP2A and SPHKAP were upregulated significantly in P by comparing to NP, while GM2A, MRPS16, APOA2 and FGF2 were downregulated significantly. Most notably, Correlation analysis revealed that TOP2A, SPHKAP, MRPS16 and FGF2were positively correlated with TG, AMH and Age, but negatively correlated with Menarche age, DBIL, FT3, Basal serum FSH and LH.Meanwhile, CCK-8 assay has shown that downregulation of FGF2 could weaken cell viability. Finally, a panel of DEPs were identified in the GCs of patients with PCOS, of which certain significant DEPs might play essential roles in the pathogenesis of PCOS, could be regarded as candidate biomarkers for PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeBiomarkersProteomicsHumansFemaleAdultGranulosa Cells

Stichwörter der Autor:innen

BiomarkersDIA proteomicDifferentially expressed proteinsParallel reaction monitoringPolycystic ovary syndrome

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China; Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, Chin…
  • Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China.
  • Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China.
  • Department of Obstetrics and Gynecology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang 321099, China.
  • Department of Quality Control, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China.
  • Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China; Jiangxi Key Laboratory of Reproductive Health, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China.

Förderung

  • Jiangxi Provincial Department of Science and Technology
  • Jiangxi Provincial Natural Science Foundation

Zitieren

APA

Liu, F., Tian, L., Zhang, Y., Deng, W., Xu, X., Zou, Y., & An, R. (2024). DIA proteomic and PRM validation through human granulose cells profiles screen suitable biomarkers for polycystic ovary syndrome patients. Journal of Proteomics, 309, 105332. https://doi.org/10.1016/j.jprot.2024.105332

Vancouver

Liu F, Tian L, Zhang Y, Deng W, Xu X, Zou Y, et al. DIA proteomic and PRM validation through human granulose cells profiles screen suitable biomarkers for polycystic ovary syndrome patients. Journal of Proteomics. 2024;309:105332. doi:10.1016/j.jprot.2024.105332

BibTeX
@article{Liu2024,
  author = {Liu, Faying and Tian, Lifeng and Zhang, Ying and Deng, Wei and Xu, Xiaoyun and Zou, Yang and An, Ruifang},
  title = {DIA proteomic and PRM validation through human granulose cells profiles screen suitable biomarkers for polycystic ovary syndrome patients},
  journal = {Journal of Proteomics},
  year = {2024},
  volume = {309},
  pages = {105332},
  doi = {10.1016/j.jprot.2024.105332}
}
Kostenlos starten →